Arbor Pharmaceuticals recalls Cetylev tablets due to swelling risk
Arbor Pharmaceuticals recalls Cetylev (acetylcysteine) effervescent tablets for oral solution. Defective packaging may cause tablets to swell and enlarge, leading to potential choking or injury.
Use caution until it’s fixed
Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning as oxygen and moisture enter the blister packaging.
Contact the company
What happened, in plain English
Arbor Pharmaceuticals is recalling Cetylev (acetylcysteine) effervescent tablets for oral solution. The tablets may swell and enlarge due to a defective blister pack seal, which could cause choking or injury if swallowed. Read more at govinfonow.com/recall/42539-arbor-pharmaceuticals-recalls-cetylev-tablets-due-to-swelling-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/42539-arbor-pharmaceuticals-recalls-cetylev-tablets-due-to-swelling-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0105-2017
Cite this page
“Arbor Pharmaceuticals recalls Cetylev tablets due to swelling risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42539-arbor-pharmaceuticals-recalls-cetylev-tablets-due-to-swelling-risk. Based on FDA recall #D-0105-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0105-2017%22&limit=1).
Why it’s dangerous
The blister packaging seal is incomplete, allowing oxygen and moisture to enter. This causes the tablets to swell and enlarge through the effervescence process, which could lead to choking or injury if swallowed.
Who’s affected
People who have the recalled Cetylev tablets (500 mg, Rx Only, 20 tablets per carton) are affected. Those who have taken the tablets recently or plan to use them are at risk of choking or injury.
How to tell if you have this one
Check for Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, Rx Only, 20 tablets per carton. The lot numbers 005C16, 006C16, 007C16 (expiring 02/2018) are affected.
- Brand
Arbor Pharmaceuticals- Category
Drug
What to do — step by step
Check for Swelling
Inspect the tablets for swelling or enlargement in the blister pack.
Discard if Swollen
If the tablets are swollen, discard them immediately and contact Arbor Pharmaceuticals for a replacement.
Where it went and when
Where it was distributed
Distributed in 14 states.
FDA distribution: “CA, FL, GA, LA, MO, MS, NC, OH, PA, SC, TN, TX, VA and WV.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: California, Florida, Georgia, Louisiana, Mississippi, Missouri, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0105-2017 (July 21, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0105-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.